Healthcare Sector Analytics

Market size, company revenue, drug approvals, clinical trials, regulation, hospitals, doctors, drug spending, labs and devices

MHRARegulator guidanceLot release and sample testingDevices and medicinesHigh confidenceLast verified October 5, 2026

MHRA Responsible Person (import) guidance

Acting as a Responsible Person (import)

Current edition

Last updated 22 December 2021

About this standard

Describes how a Responsible Person (import) confirms QP certification and independent batch release certificates for medicines imported into Great Britain from approved countries.

Recognition by market

Whether the market recognizes, harmonizes or adopts this standard, and which edition it accepts

No market listing is published yet.

Testing requirements that cite it

Open the market page and its pathway pages for the full requirement, protocol and report content

United Kingdom

Related standards: EudraLex Volume 4 Annex 16, HC Lot Release Program guidance, TGA vaccine batch release, MFDS imported drug management regulation, MFDS national lot release regulation, RDC 669/2022, RDC 670/2022, RDC 900/2024, RDC 944/2024, SFDA lot release policy, Taiwan biological product lot release regulations. See all standards.

Not legal or regulatory advice. Check the current official rules before you act. Parts of the approvals data are official open data reused under open licences. Data sources.

LinkedInLinkedInXXYouTubeYouTube